Diabetes tolerogenic vaccines targeting antigen-specific inflammation

References

• Gonzalez-Rey E, Ganea D, Delgado M. Neuropeptides: keeping the balance between pathogen immunity and immune tolerance. Curr Opin Pharmacol 2010; 10(4):473-81; PMID:20399708; http://dx.doi.org/10.1016/j.coph.2010.03.003
   PubMedGoogle Scholar
• Nagler-Anderson C. Tolerance and immunity in the intestinal immune system. Crit Rev Immunol 2000; 20(2):103-20; PMID:10872893; http://dx.doi.org/10.1615/CritRevImmunol.v20.i2.20
   PubMedGoogle Scholar
• Tse MT. Autoimmunity: Particulate promotion of tolerance. Nat Rev Immunol 2013; 13(1):6-7; PMID:23237965; http://dx.doi.org/10.1038/nri3373
   PubMedGoogle Scholar
• Bluestone JA, Herold K, Eisenbarth G. Genetics, pathogenesis and clinical interventions in type 1 diabetes. Nature 2010; 464(7293):1293-300; PMID:20432533; http://dx.doi.org/10.1038/nature08933
   PubMed Web of Science ®Google Scholar
• Galli SJ, Tsai M, Piliponsky AM. The development of allergic inflammation. Nature 2008; 454(7203):445-54; PMID:18650915; http://dx.doi.org/10.1038/nature07204
   PubMed Web of Science ®Google Scholar
• Lloyd CM, Hessel EM. Functions of T cells in asthma: more than just T(H)2 cells. Nat Rev Immunol 2010; 10(12):838-48; PMID:21060320; http://dx.doi.org/10.1038/nri2870
   PubMed Web of Science ®Google Scholar
• Libby P. Inflammation in atherosclerosis. Nature 2002; 420(6917):868-74; PMID:12490960; http://dx.doi.org/10.1038/nature01323
   PubMed Web of Science ®Google Scholar
• Querfurth HW, LaFerla FM. Alzheimer's disease. N Engl J Med 2010; 362(4):329-44; PMID:20107219; http://dx.doi.org/10.1056/NEJMra0909142
   PubMed Web of Science ®Google Scholar
• Wyss-Coray T, Rogers J. Inflammation in Alzheimer disease-a brief review of the basic science and clinical literature. Cold Spring Harb Perspect Med 2012; 2(1):a006346; PMID:22315714; http://dx.doi.org/10.1101/cshperspect.a006346
   PubMed Web of Science ®Google Scholar
• Wyss-Coray T. Inflammation in Alzheimer disease: driving force, bystander or beneficial response? Nat Med 2006; 12(9):1005-15; PMID:16960575
   PubMed Web of Science ®Google Scholar
• Williams KJ, Tabas I. Atherosclerosis and inflammation. Science 2002; 297(5581):521-2; PMID:12143880; http://dx.doi.org/10.1126/science.297.5581.521
   PubMed Web of Science ®Google Scholar
• McGeer EG, McGeer PL. Brain inflammation in Alzheimer disease and the therapeutic implications. Curr Pharm Des 1999; 5(10):821-36; PMID:10526088
   PubMed Web of Science ®Google Scholar
• Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell 2010; 140(6):883-99; PMID:20303878; http://dx.doi.org/10.1016/j.cell.2010.01.025
   PubMed Web of Science ®Google Scholar
• Miller SD, Turley DM, Podojil JR. Antigen-specific tolerance strategies for the prevention and treatment of autoimmune disease. Nat Rev Immunol 2007; 7(9):665-77; PMID:17690713; http://dx.doi.org/10.1038/nri2153
   PubMed Web of Science ®Google Scholar
• Bingham CO 3rd, Looney RJ, Deodhar A, Halsey N, Greenwald M, Codding C, Trzaskoma B, Martin F, Agarwal S, Kelman A. Immunization responses in rheumatoid arthritis patients treated with rituximab: results from a controlled clinical trial. Arthritis Rheum 2010; 62(1):64-74; PMID:20039397; http://dx.doi.org/10.1002/art.25034
   PubMed Web of Science ®Google Scholar
• Prentice HG, Blacklock HA, Janossy G, Bradstock KF, Skeggs D, Goldstein G, Hoffbrand AV. Use of anti-T-cell monoclonal antibody OKT3 to prevent acute graft-versus-host disease in allogeneic bone-marrow transplantation for acute leukaemia. Lancet 1982; 1(8274):700-3; PMID:6122004; http://dx.doi.org/10.1016/S0140-6736(82)92619-8
   PubMedGoogle Scholar
• Favas C, Isenberg DA. B-cell-depletion therapy in SLE–what are the current prospects for its acceptance? Nat Rev Rheumatol 2009; 5(12):711-6; PMID:19946298; http://dx.doi.org/10.1038/nrrheum.2009.218
   PubMed Web of Science ®Google Scholar
• Jokipii AM, Jokipii L. Suppression of cell-mediated immunity by cyclophosphamide: its independence of concomitant B cell response. Cell Immunol 1973; 9(3):477-81; PMID:4543314; http://dx.doi.org/10.1016/0008-8749(73)90063-4
   PubMedGoogle Scholar
• Blaha P, Bigenzahn S, Koporc Z, Schmid M, Langer F, Selzer E, Bergmeister H, Wrba F, Kurtz J, Kiss C, et al. The influence of immunosuppressive drugs on tolerance induction through bone marrow transplantation with costimulation blockade. Blood 2003; 101(7):2886-93; PMID:12433677; http://dx.doi.org/10.1182/blood-2002-10-3014
   PubMed Web of Science ®Google Scholar
• Welsh RM, Fujinami RS. Pathogenic epitopes, heterologous immunity and vaccine design. Nat Rev Microbiol 2007; 5(7):555-63; PMID:17558423; http://dx.doi.org/10.1038/nrmicro1709
   PubMed Web of Science ®Google Scholar
• Finco O, Rappuoli R. Designing vaccines for the twenty-first century society. Front Immunol 2014; 5:12; PMID:24478777; http://dx.doi.org/10.3389/fimmu.2014.00012
   PubMed Web of Science ®Google Scholar
• Rappuoli R, Mandl CW, Black S, De Gregorio E. Vaccines for the twenty-first century society. Nat Rev Immunol 2011; 11(12):865-72; PMID:22051890
   PubMed Web of Science ®Google Scholar
• Czerkinsky C, Anjuere F, McGhee JR, George-Chandy A, Holmgren J, Kieny MP, Fujiyashi K, Mestecky JF, Pierrefite-Carle V, Rask C, et al. Mucosal immunity and tolerance: relevance to vaccine development. Immunol Rev 1999; 170:197-222; PMID:10566152; http://dx.doi.org/10.1111/j.1600-065X.1999.tb01339.x
   PubMed Web of Science ®Google Scholar
• Valenta R. The future of antigen-specific immunotherapy of allergy. Nat Rev Immunol 2002; 2(6):446-53; PMID:12093011
   PubMed Web of Science ®Google Scholar
• Mayer L, Shao L. Therapeutic potential of oral tolerance. Nat Rev Immunol 2004; 4(6):407-19; PMID:15173830; http://dx.doi.org/10.1038/nri1370
   PubMed Web of Science ®Google Scholar
• Pabst O, Mowat AM. Oral tolerance to food protein. Mucosal Immunol 2012; 5(3):232-9; PMID:22318493; http://dx.doi.org/10.1038/mi.2012.4
   PubMed Web of Science ®Google Scholar
• Larche M, Akdis CA, Valenta R. Immunological mechanisms of allergen-specific immunotherapy. Nat Rev Immunol 2006; 6(10):761-71; PMID:16998509; http://dx.doi.org/10.1038/nri1934
   PubMed Web of Science ®Google Scholar
• Ciprandi G, Marseglia GL, Tosca MA. Allergen-specific immunotherapy: an update on immunological mechanisms of action. Monaldi Arch Chest Dis 2006 65(1):34-7; PMID:16700191
   PubMedGoogle Scholar
• Herold KC, Gitelman SE, Masharani U, Hagopian W, Bisikirska B, Donaldson D, Rother K, Diamond B, Harlan DM, Bluestone JA. A single course of anti-CD3 monoclonal antibody hOKT3gamma1(Ala-Ala) results in improvement in C-peptide responses and clinical parameters for at least 2 years after onset of type 1 diabetes. Diabetes 2005 54(6):1763-9; PMID:15919798; http://dx.doi.org/10.2337/diabetes.54.6.1763
   PubMed Web of Science ®Google Scholar
• Lunardon L, Payne AS. Rituximab for autoimmune blistering diseases: recent studies, new insights. G Ital Dermatol Venereol 2012; 147(3):269-76; PMID:22648328
   PubMed Web of Science ®Google Scholar
• Kneitz C, Wilhelm M, Tony HP. Effective B cell depletion with rituximab in the treatment of autoimmune diseases. Immunobiology 2002; 206(5):519-27; PMID:12607727; http://dx.doi.org/10.1078/0171-2985-00200
   PubMedGoogle Scholar
• Zagury D, Gallo RC. Anti-cytokine Ab immune therapy: present status and perspectives. Drug Discov Today 2004; 9(2):72-81; PMID:15012931; http://dx.doi.org/10.1016/S1359-6446(03)02955-6
   PubMedGoogle Scholar
• O'Shea JJ, Ma A, Lipsky P. Cytokines and autoimmunity. Nat Rev Immunol 2002; 2(1):37-45; PMID:11905836; http://dx.doi.org/10.1038/nri702
   PubMed Web of Science ®Google Scholar
• Thomson AW, Carroll PB, McCauley J, Woo J, Abu-Elmagd K, Starzl TE, Van Thiel DH. FK 506: a novel immunosuppressant for treatment of autoimmune disease. Rationale and preliminary clinical experience at the University of Pittsburgh. Springer Semin Immunopathol 1993; 14(4):323-44; PMID:7686690; http://dx.doi.org/10.1007/BF00192307
   PubMedGoogle Scholar
• Thomson AW, Starzl TE. FK 506 and autoimmune disease: perspective and prospects. Autoimmunity 1992; 12(4):303-13; PMID:1382646; http://dx.doi.org/10.3109/08916939209148473
   PubMed Web of Science ®Google Scholar
• Schwaiger T, van den Brandt C, Fitzner B, Zaatreh S, Kraatz F, Dummer A, Nizze H, Evert M, Bröker BM, Brunner-Weinzierl MC, et al. Autoimmune pancreatitis in MRL/Mp mice is a T cell-mediated disease responsive to cyclosporine A and rapamycin treatment. Gut 2014; 63(3):494-505; PMID:23564336; http://dx.doi.org/10.1136/gutjnl-2012-303635
   PubMedGoogle Scholar
• Suzuki K, Yan H, Li XK, Amemiya H, Suzuki S, Hiromitsu K. Prevention of experimentally induced autoimmune type I diabetes in rats by the new immunosuppressive reagent FTY720. Transplant Proc 1998; 30(4):1044-5; PMID:9636421; http://dx.doi.org/10.1016/S0041-1345(98)00143-2
   PubMedGoogle Scholar
• Papadopoulos D, Rundle J, Patel R, Marshall I, Stretton J, Eaton R, Richardson JC, Gonzalez MI, Philpott KL, Reynolds R. FTY720 ameliorates MOG-induced experimental autoimmune encephalomyelitis by suppressing both cellular and humoral immune responses. J Neurosci Res 2010; 88(2):346-59; PMID:19658199; http://dx.doi.org/10.1002/jnr.22196
   PubMedGoogle Scholar
• Anderson RP, Jabri B. Vaccine against autoimmune disease: antigen-specific immunotherapy. Curr Opin Immunol 2013; 25(3):410-7; PMID:23478068; http://dx.doi.org/10.1016/j.coi.2013.02.004
   PubMed Web of Science ®Google Scholar
• Brandtzaeg P. History of oral tolerance and mucosal immunity. Ann N Y Acad Sci 1996; 778:1-27; PMID:8610963; http://dx.doi.org/10.1111/j.1749-6632.1996.tb21110.x
   PubMed Web of Science ®Google Scholar
• Noon L CB. Prophylactic inoculation against hay fever. Lancet 1911; 177: 1572–73; http://dx.doi.org/10.1016/S0140-6736(00)78276-6.
   Google Scholar
• Vandenbark AA, Morgan E, Bartholomew R, Bourdette D, Whitham R, Carlo D, Gold D, Hashim G, Offner H. TCR peptide therapy in human autoimmune diseases. Neurochem Res 2001; 26(6):713-30; PMID:11519731; http://dx.doi.org/10.1023/A:1010951706830
   PubMedGoogle Scholar
• Larche M, Wraith DC. Peptide-based therapeutic vaccines for allergic and autoimmune diseases. Nat Med 2005; 11(4 Suppl):S69-76; PMID:15812493; http://dx.doi.org/10.1038/nm1226
   PubMedGoogle Scholar
• Mor G, Yamshchikov G, Sedegah M, Takeno M, Wang R, Houghten RA, Hoffman S, Klinman DM. Induction of neonatal tolerance by plasmid DNA vaccination of mice. J Clin Invest 1996; 98(12):2700-5; PMID:8981914; http://dx.doi.org/10.1172/JCI119094
   PubMedGoogle Scholar
• Jin H, Kang Y, Zheng G, Xie Q, Xiao C, Zhang X, Yu Y, Zhu K, Zhao G, Zhang F, et al. Induction of active immune suppression by co-immunization with DNA- and protein-based vaccines. Virology 2005; 337(1):183-91; PMID:15914231; http://dx.doi.org/10.1016/j.virol.2005.03.029
   PubMedGoogle Scholar
• Jin J, Ding Z, Meng F, Liu Q, Ng T, Hu Y, Zhao G, Zhai B, Chu HJ, Wang B. An immunotherapeutic treatment against flea allergy dermatitis in cats by co-immunization of DNA and protein vaccines. Vaccine 2010; 28(8):1997-2004; PMID:20188255; http://dx.doi.org/10.1016/j.vaccine.2009.10.092
   PubMedGoogle Scholar
• Wang S, Yu Y, Geng S, Wang D, Zhang L, Xie X, Wu B, Li C, Xu H, Li X, et al. A coimmunization vaccine of Abeta42 ameliorates cognitive deficits without brain inflammation in an Alzheimer's disease model. Alzheimers Res Ther 2014; 6(3):26; PMID:24987466; http://dx.doi.org/10.1186/alzrt256
   PubMedGoogle Scholar
• Kang Y, Xu L, Wang B, Chen A, Zheng G. Cutting edge: Immunosuppressant as adjuvant for tolerogenic immunization. J Immunol 2008; 180(8):5172-6; PMID:18390698; http://dx.doi.org/10.4049/jimmunol.180.8.5172
   PubMedGoogle Scholar
• Zhang W, Jin H, Hu Y, Yu Y, Li X, Ding Z, Kang Y, Wang B. Protective response against type 1 diabetes in nonobese diabetic mice after coimmunization with insulin and DNA encoding proinsulin. Hum Gene Ther 2010; 21(2):171-8; PMID:19788384; http://dx.doi.org/10.1089/hum.2009.095
   PubMedGoogle Scholar
• Li J, Jin H, Zhang F, Du X, Zhao G, Yu Y, Wang B. Treatment of autoimmune ovarian disease by co-administration with mouse zona pellucida protein 3 and DNA vaccine through induction of adaptive regulatory T cells. J Gene Med 2008; 10(7):810-20; PMID:18452236; http://dx.doi.org/10.1002/jgm.1200
   PubMedGoogle Scholar
• Jin H, Xiao C, Geng S, Hu Y, She R, Yu Y, Kang Y, Wang B. Protein/DNA vaccine-induced antigen-specific Treg confer protection against asthma. Eur J Immunol 2008; 38(9):2451-63; PMID:18792401; http://dx.doi.org/10.1002/eji.200737899
   PubMedGoogle Scholar
• Jin H, Kang Y, Zhao L, Xiao C, Hu Y, She R, Yu Y, Du X, Zhao G, Ng T, et al. Induction of adaptive T regulatory cells that suppress the allergic response by coimmunization of DNA and protein vaccines. J Immunol 2008; 180(8):5360-72; PMID:18390718; http://dx.doi.org/10.4049/jimmunol.180.8.5360
   PubMedGoogle Scholar
• Sakaguchi S, Yamaguchi T, Nomura T, Ono M. Regulatory T cells and immune tolerance. Cell 2008; 133(5):775-87; PMID:18510923; http://dx.doi.org/10.1016/j.cell.2008.05.009
   PubMed Web of Science ®Google Scholar
• Vignali DA, Collison LW, Workman CJ. How regulatory T cells work. Nat Rev Immunol 2008; 8(7):523-32; PMID:18566595; http://dx.doi.org/10.1038/nri2343
   PubMed Web of Science ®Google Scholar
• Bluestone JA, Abbas AK. Natural versus adaptive regulatory T cells. Nat Rev Immunol 2003; 3(3):253-7; PMID:12658273; http://dx.doi.org/10.1038/nri1032
   PubMed Web of Science ®Google Scholar
• Josefowicz SZ, Lu LF, Rudensky AY. Regulatory T cells: mechanisms of differentiation and function. Annu Rev Immunol 2012; 30:531-64; PMID:22224781; http://dx.doi.org/10.1146/annurev.immunol.25.022106.141623
   PubMed Web of Science ®Google Scholar
• Kang Y, Jin H, Zheng G, Du X, Xiao C, Zhang X, Geng S, Li X, Wang J, Chen A, et al. Co-inoculation of DNA and protein vaccines induces antigen-specific T cell suppression. Biochem Biophys Res Commun 2007; 353(4):1034-9; PMID:17204242; http://dx.doi.org/10.1016/j.bbrc.2006.12.124
   PubMedGoogle Scholar
• Li J, Geng S, Xie X, Liu H, Zheng G, Sun X, Zhao G, Wan Y, Wu Y, Chen X, et al. Caveolin-1-mediated negative signaling plays a critical role in the induction of regulatory dendritic cells by DNA and protein coimmunization. J Immunol 2012; 189(6):2852-9; PMID:22904311; http://dx.doi.org/10.4049/jimmunol.1102828
   PubMedGoogle Scholar
• Zheng G, Zhong S, Geng Y, Munirathinam G, Cha I, Reardon C, Getz GS, van Rooijen N, Kang Y, Wang B, et al. Dexamethasone promotes tolerance in vivo by enriching CD11clo CD40lo tolerogenic macrophages. Eur J Immunol 2013; 43(1):219-27; PMID:23001956; http://dx.doi.org/10.1002/eji.201242468
   PubMed Web of Science ®Google Scholar
• Chen X, Murakami T, Oppenheim JJ, Howard OM. Differential response of murine CD4+CD25+ and CD4+CD25- T cells to dexamethasone-induced cell death. Eur J Immunol 2004; 34(3):859-69; PMID:14991616; http://dx.doi.org/10.1002/eji.200324506
   PubMedGoogle Scholar
• Chen A, Geng Y, Ke H, Constant L, Yan Z, Pan Y, Lee P, Tan I, Williams K, George S, et al. Cutting edge: Dexamethasone potentiates the responses of both regulatory T cells and B-1 cells to antigen immunization in the ApoE(-/-) mouse model of atherosclerosis. J Immunol 2014; 193(1):35-9; PMID:24899497; http://dx.doi.org/10.4049/jimmunol.1302469
   PubMedGoogle Scholar
• Robb RJ, Lineburg KE, Kuns RD, Wilson YA, Raffelt NC, Olver SD, Varelias A, Alexander KA, Teal BE, Sparwasser T, et al. Identification and expansion of highly suppressive CD8(+)FoxP3(+) regulatory T cells after experimental allogeneic bone marrow transplantation. Blood 2012; 119(24):5898-908; PMID:22538855; http://dx.doi.org/10.1182/blood-2011-12-396119
   PubMed Web of Science ®Google Scholar
• Tsai YG, Lee CY, Lin TY, Lin CY. CD8(+) Treg cells associated with decreasing disease activity after intravenous methylprednisolone pulse therapy in lupus nephritis with heavy proteinuria. PLoS One 2014; 9(1):e81344; PMID:24475019
   PubMed Web of Science ®Google Scholar
• Chesneau M, Michel L, Degauque N, Brouard S. Regulatory B cells and tolerance in transplantation: from animal models to human. Front Immunol 2013; 4:497; PMID:24427159; http://dx.doi.org/10.3389/fimmu.2013.00497
   PubMed Web of Science ®Google Scholar
• Yoshizaki A, Miyagaki T, DiLillo DJ, Matsushita T, Horikawa M, Kountikov EI, Spolski R, Poe JC, Leonard WJ, Tedder TF. Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions. Nature 2012; 491(7423):264-8; PMID:23064231; http://dx.doi.org/10.1038/nature11501
   PubMed Web of Science ®Google Scholar
• Yang M, Rui K, Wang S, Lu L. Regulatory B cells in autoimmune diseases. Cell Mol Immunol 2013; 10(2):122-32; PMID:23292280; http://dx.doi.org/10.1038/cmi.2012.60
   PubMedGoogle Scholar
• Kalampokis I, Yoshizaki A, Tedder TF. IL-10-producing regulatory B cells (B10 cells) in autoimmune disease. Arthritis Res Ther 2013; 15(Suppl 1):S1; PMID:23566714; http://dx.doi.org/10.1186/ar3907
   PubMed Web of Science ®Google Scholar
• Di Lorenzo TP, Peakman M, Roep BO. Translational mini-review series on type 1 diabetes: Systematic analysis of T cell epitopes in autoimmune diabetes. Clin Exp Immunol 2007; 148(1):1-16; PMID:17349009; http://dx.doi.org/10.1111/j.1365-2249.2006.03244.x
   PubMedGoogle Scholar
• Pinkse GG, Tysma OH, Bergen CA, Kester MG, Ossendorp F, van Veelen PA, Keymeulen B, Pipeleers D, Drijfhout JW, Roep BO. Autoreactive CD8 T cells associated with beta cell destruction in type 1 diabetes. Proc Natl Acad Sci U S A 2005; 102(51):18425-30; PMID:16339897; http://dx.doi.org/10.1073/pnas.0508621102
   PubMed Web of Science ®Google Scholar
• Caspi RR. Tregitopes switch on Tregs. Blood 2008; 112(8):3003-4; PMID:18840719; http://dx.doi.org/10.1182/blood-2008-08-173609
   PubMedGoogle Scholar
• Fissolo N, Costa C, Nurtdinov RN, Bustamante MF, Llombart V, Mansilla MJ, Espejo C, Montalban X, Comabella M. Treatment with MOG-DNA vaccines induces CD4+CD25+FoxP3+ regulatory T cells and up-regulates genes with neuroprotective functions in experimental autoimmune encephalomyelitis. J Neuroinflammation 2012; 9:139; PMID:22727044; http://dx.doi.org/10.1186/1742-2094-9-139
   PubMedGoogle Scholar